Left to right: Scribenote founders Emily Merry; Katie Gallagher, DVM; Ryan Gallagher; Alina Pavel.

Scribenote, an AI-powered medical scribe designed to alleviate documentation burden on veterinarians, has successfully raised $8.2 million in seed funding. Co-founded by University of Waterloo alumni Ryan Gallagher and Alina Pavel, along with Katie Gallagher, DVM, and veterinary student Emily Merry, Scribenote captures audio from conversations between veterinarians and clients—using AI to generate accurate medical records in just minutes.

The software automates not only medical records but also dental charts and client communications, enabling veterinarians to concentrate on patient care and relationship-building. With clients across Canada and the U.S., Scribenote has generated over 1.5 million notes, collectively saving veterinarians around 125,000 hours of notetaking.

“Scribenote is not just about saving time; it’s about improving the quality of veterinary care and the lives of those who provide it,” says Ryan Gallagher, co-founder and CEO of Scribenote. “By automating the documentation process, we’re enabling veterinarians to focus more on their patients and less on paperwork.

After initially working from Velocity, the University of Waterloo’s incubator, the company has expanded to its own Kitchener office, accommodating a growing team of 20. The investment round was led by Andreessen Horowitz (a16z), with additional contributions from Inovia Capital, the Velocity Fund, and various angel investors.

With this new funding, Scribenote plans to advance its AI technology and expand its platform, aiming to create personalized AI scribes for veterinary professionals. Initially developed with just $250,000 in pre-seed funding, the co-founders envision a future where AI scribing eliminates unnecessary clicks and keystrokes, further easing the workload in a profession already under significant stress.

“We see a world where pet care is so affordable and accessible that anyone can experience the precious bond between animals and humans, and we want to build technology that increasingly enables that world,” Gallagher says.